Cargando…
Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification
BACKGROUND: The Ki-67 Labelling Index (LI) is used as an ancillary tool in glioma diagnostics. Interobserver variability has been reported and no precise guidelines are available. Nor is it known whether novel digital approaches would be an advantage. Our aim was to evaluate the inter- and intraobse...
Autores principales: | Nielsen, Ljudmilla A. G., Bangsø, Julie A., Lindahl, Kim H., Dahlrot, Rikke H., Hjelmborg, Jacob v. B., Hansen, Steinbjørn, Kristensen, Bjarne W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994254/ https://www.ncbi.nlm.nih.gov/pubmed/29885671 http://dx.doi.org/10.1186/s13000-018-0711-2 |
Ejemplares similares
-
Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells
por: Dahlrot, Rikke H., et al.
Publicado: (2021) -
Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype
por: Munthe, Sune, et al.
Publicado: (2016) -
Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016) -
Expression and prognostic value of JAM-A in gliomas
por: Rosager, Ann Mari, et al.
Publicado: (2017) -
An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer
por: Shui, Ruohong, et al.
Publicado: (2015)